| Component: (Network and Table) | |
|---|---|
| Network | 100320 - Disclosure - Capital Structure (Tables) (http://www.recropharma.com/20161231/taxonomy/role/DisclosureCapitalStructureTables) |
| Table | (Implied) |
| Reporting Entity [Axis] | 0001588972 (http://www.sec.gov/CIK) |
| Equity [Abstract] | Period [Axis] | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2016-01-01 - 2016-12-31 | |||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||
Schedule of Warrants Outstanding to Purchase Shares of Common Stock | As of December 31, 2016, the Company had the following warrants outstanding to purchase shares of the Company’s common stock:
| ||||||||||||||||||||||||||||